HBM BioVentures AG is a direct private equity investment company managed by HBM Partners Limited. It was founded in 2001 and has been listed on the Swiss Stock Exchange since February 2008. The company pursues a global venture and growth capital investment strategy in the biotechnology and healthcare sector.